1
|
Mbugi NO, Maina G, Chacha M, Mbega E. In vivo anti-schistosomal activity of the methanol extracts from Searsia longipes and Lannea schimperi. Parasite Epidemiol Control 2024; 27:e00383. [PMID: 39445037 PMCID: PMC11497427 DOI: 10.1016/j.parepi.2024.e00383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2024] [Revised: 08/31/2024] [Accepted: 10/03/2024] [Indexed: 10/25/2024] Open
Abstract
Schistosomiasis is a disease caused by the flat worms under the genus Schistosoma. The disease is prominent in tropical and sub tropical countries and it is manifested in two forms; the acute and the chronic form. Treatment and control of the schistosomiasis is constrained with various factors including immerging worm resistance and selective efficacy of the current recommended drug of choice. This therefore calls for the search of new approaches to offset the problems. The aim of this study was to investigate the efficacy of the methanolic extract from Searsia longipes and Lannea schimperi against Schistosoma mansoni by using animal model. Swiss albino mice were used for the efficacy testing, whereby, for each extract, 5 groups of mice were used, and each contained 5 mice. Three different doses were administered to three groups, whereas the remaining two groups were used as negative and positive control arms. Efficacies were assessed based on the reduction of the worm eggs in the faeces and organs, body weight gain, loss of liver weight, as well as reduction of worm burden. Both extracts demonstrated significant egg and worm reduction, which was directly proportional to the dose increment. At the highest dose used, Searsia longipes expressed the higher percentage egg reduction (73.33 %), whereas Lannea schimperi demonstrated the higher worm burden reduction (68.53 %). The present study provides strong evidence of the anti-schistosomal activity of the extracts from both S. longipes and L. schimperi. These findings are a significant step forward, suggesting that these plants could be a promising alternative medicine for the treatment of schistosomiasis. However, further investigations are warranted to isolate the compound responsible for this activity and to assess the sub-acute toxicity of the plant extracts. This next phase of research is crucial for advancing our understanding and potential use of these plant extracts.
Collapse
Affiliation(s)
- Nicolaus Omari Mbugi
- The Nelson Mandela African Institution of Science and Technology, School of Life Sciences and Bioengineering, P.O. Box 447, Arusha, Tanzania
- Mbeya University of Science and Technology, College of Science and Technical Education, P.O. Box 131, Mbeya, Tanzania
| | | | - Musa Chacha
- Arusha Technical College, P.O. Box 296, Arusha, Tanzania
| | - Ernest Mbega
- The Nelson Mandela African Institution of Science and Technology, School of Life Sciences and Bioengineering, P.O. Box 447, Arusha, Tanzania
| |
Collapse
|
2
|
Vahekeni N, Brillatz T, Rahmaty M, Cal M, Keller-Maerki S, Rocchetti R, Kaiser M, Sax S, Mattli K, Wolfram E, Marcourt L, Queiroz EF, Wolfender JL, Mäser P. Antiprotozoal Activity of Plants Used in the Management of Sleeping Sickness in Angola and Bioactivity-Guided Fractionation of Brasenia schreberi J.F.Gmel and Nymphaea lotus L. Active against T. b. rhodesiense. Molecules 2024; 29:1611. [PMID: 38611890 PMCID: PMC11013945 DOI: 10.3390/molecules29071611] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2024] [Revised: 03/20/2024] [Accepted: 03/22/2024] [Indexed: 04/14/2024] Open
Abstract
Folk medicine is widely used in Angola, even for human African trypanosomiasis (sleeping sickness) in spite of the fact that the reference treatment is available for free. Aiming to validate herbal remedies in use, we selected nine medicinal plants and assessed their antitrypanosomal activity. A total of 122 extracts were prepared using different plant parts and solvents. A total of 15 extracts from seven different plants exhibited in vitro activity (>70% at 20 µg/mL) against Trypanosoma brucei rhodesiense bloodstream forms. The dichloromethane extract of Nymphaea lotus (leaves and leaflets) and the ethanolic extract of Brasenia schreberi (leaves) had IC50 values ≤ 10 µg/mL. These two aquatic plants are of particular interest. They are being co-applied in the form of a decoction of leaves because they are considered by local healers as male and female of the same species, the ethnotaxon "longa dia simbi". Bioassay-guided fractionation led to the identification of eight active molecules: gallic acid (IC50 0.5 µg/mL), methyl gallate (IC50 1.1 µg/mL), 2,3,4,6-tetragalloyl-glucopyranoside, ethyl gallate (IC50 0.5 µg/mL), 1,2,3,4,6-pentagalloyl-β-glucopyranoside (IC50 20 µg/mL), gossypetin-7-O-β-glucopyranoside (IC50 5.5 µg/mL), and hypolaetin-7-O-glucoside (IC50 5.7 µg/mL) in B. schreberi, and 5-[(8Z,11Z,14Z)-heptadeca-8,11,14-trienyl] resorcinol (IC50 5.3 µg/mL) not described to date in N. lotus. Five of these active constituents were detected in the traditional preparation. This work provides the first evidence for the ethnomedicinal use of these plants in the management of sleeping sickness in Angola.
Collapse
Affiliation(s)
- Nina Vahekeni
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Théo Brillatz
- School of Pharmaceutical Sciences, University of Geneva, CMU, 1211 Geneva, Switzerland; (T.B.); (L.M.); (E.F.Q.); (J.-L.W.)
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU, 1211 Geneva, Switzerland
| | - Marjan Rahmaty
- School of Pharmaceutical Sciences, University of Geneva, CMU, 1211 Geneva, Switzerland; (T.B.); (L.M.); (E.F.Q.); (J.-L.W.)
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU, 1211 Geneva, Switzerland
| | - Monica Cal
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Sonja Keller-Maerki
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Romina Rocchetti
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Marcel Kaiser
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Sibylle Sax
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| | - Kevin Mattli
- Phytopharmacy & Natural Products, Institute of Chemistry and Biotechnology, Zürich University of Applied Sciences (ZHAW), 8820 Wädenswil, Switzerland (E.W.)
| | - Evelyn Wolfram
- Phytopharmacy & Natural Products, Institute of Chemistry and Biotechnology, Zürich University of Applied Sciences (ZHAW), 8820 Wädenswil, Switzerland (E.W.)
| | - Laurence Marcourt
- School of Pharmaceutical Sciences, University of Geneva, CMU, 1211 Geneva, Switzerland; (T.B.); (L.M.); (E.F.Q.); (J.-L.W.)
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU, 1211 Geneva, Switzerland
| | - Emerson Ferreira Queiroz
- School of Pharmaceutical Sciences, University of Geneva, CMU, 1211 Geneva, Switzerland; (T.B.); (L.M.); (E.F.Q.); (J.-L.W.)
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU, 1211 Geneva, Switzerland
| | - Jean-Luc Wolfender
- School of Pharmaceutical Sciences, University of Geneva, CMU, 1211 Geneva, Switzerland; (T.B.); (L.M.); (E.F.Q.); (J.-L.W.)
- Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, CMU, 1211 Geneva, Switzerland
| | - Pascal Mäser
- Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4123 Allschwil, Switzerland; (M.C.); (S.K.-M.); (R.R.); (M.K.); (S.S.); (P.M.)
- Faculty of Science, University of Basel, 4002 Basel, Switzerland
| |
Collapse
|
3
|
Patel DK, Patel K. Biological Potential of Kakkalide in Medicine for the Treatment of Human Disorders: An Overview of Pharmacological Aspects. Curr Drug Res Rev 2024; 16:157-163. [PMID: 37622718 DOI: 10.2174/2589977515666230824152740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2023] [Revised: 05/04/2023] [Accepted: 06/05/2023] [Indexed: 08/26/2023]
Abstract
BACKGROUND Pueraria lobata is an important herbal medicine of Fabaceae family that has been clinically used in Traditional Chinese Medicine to counteract human disorders and associated secondary complications. Kakkalide also called irisolidone 7-xylosylglucoside is an isoflavonoid of Puerariae flos, Pueraria lobata and Flos Puerariae. Moreover, Kakkalide has a wide range of bioactivities in medicine. METHODS Biological potential of kakkalide was investigated in the present work through scientific data analysis of different scientific research work on kakkalide in order to know its therapeutic potential in medicine. Scientific data on Pueraria lobata were collected and analyzed in the present work. All the scientific data were collected from Google, Google Scholar, Scopus, and Science Direct in the present work. RESULTS Scientific data analysis of kakkalide revealed its biological importance and therapeutic potential in medicine. The present investigation signified kakkalide's effectiveness in inflammatory diseases, prostaglandin E2 production, liver complication, gastric injury, alcoholism, insulinresistant endothelial dysfunction, aldose reductase enzyme, hyperlipidemia, estrogenic activity, and stroke. In addition, the bioavailability of kakkalide was also discussed in the present paper. Present work also revealed the significance of analytical techniques for the separation, isolation and identification of kakkalide in different biological and non-biological samples. CONCLUSION Present paper signified the health-beneficial aspects of kakkalide in medicine.
Collapse
Affiliation(s)
- Dinesh Kumar Patel
- Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj, 211007, Uttar Pradesh, India
| | - Kanika Patel
- Department of Pharmaceutical Sciences, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj, 211007, Uttar Pradesh, India
| |
Collapse
|
4
|
Teratogenic Evaluation of 80% Ethanol Extract of Embelia schimperi Vatke Fruits on Rat Embryo and Fetuses. J Toxicol 2022; 2022:4310521. [PMID: 36317073 PMCID: PMC9617728 DOI: 10.1155/2022/4310521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2022] [Revised: 09/20/2022] [Accepted: 10/05/2022] [Indexed: 11/18/2022] Open
Abstract
Introduction Embelia schimperi Vatke (family Myrsinaceae) is a commonly consumed anthelminthic plant in Ethiopia. The plant has significant efficacy in treating intestinal worms. However, there are limited data about the safety/toxicity of the plant. Moreover, the teratogenic effect of the plant is not yet well studied despite significant number of Ethiopian mothers consuming herbal medication during their pregnancy. Purpose This study aimed to evaluate the teratogenic effect of the hydroalcoholic extract of E. schimperi fruit on rat embryos and fetuses. Methods Pregnant albino Wistar rats were treated with 80% hydroalcoholic fruit extract of E. schimperi at 250 mg/kg, 500 mg/kg, and 1000 mg/kg dosage, whilst the controls were pair-fed and ad libitum groups. Maternal food intake, maternal weight gain, number of implantations, number of prior resorptions, fetal viability, fetal weight, fetal and embryonic crown-ramp length, placental weight, placental gross morphology and histopathology of placental tissue, number of somites, embryonic system, gross/visceral morphological malformations, and ossification centers were evaluated as teratogenicity indices. Results The crude extract of E. schimperi did not exhibit a significant difference in most developmental indices including the development of a circulatory system, nervous system, and musculoskeletal systems among treated animals and the controls. However, histopathological evaluation of placentas from the treatment groups showed that inflammatory reactions and calcifications compared to the pair-fed and ad libitum controls. Conclusion Administration of the 80% hydroalcoholic extract of E. schimperi fruit during the period of organogenesis in rats did not show a significant toxic effect on embryonic and fetal developmental indices. However, it might affect the structural integrity of the placenta as it is evidenced by inflammatory reactions and calcifications of decidua basalis of rat placenta.
Collapse
|
5
|
do Carmo MAV, Fidelis M, Sanchez CA, Castro AP, Camps I, Colombo FA, Marques MJ, Myoda T, Granato D, Azevedo L. Camu-camu (Myrciaria dubia) seeds as a novel source of bioactive compounds with promising antimalarial and antischistosomicidal properties. Food Res Int 2020; 136:109334. [DOI: 10.1016/j.foodres.2020.109334] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2020] [Revised: 05/12/2020] [Accepted: 05/16/2020] [Indexed: 12/23/2022]
|
6
|
Sulaiman, Shah S, Khan S, Bussmann RW, Ali M, Hussain D, Hussain W. Quantitative Ethnobotanical Study of Indigenous Knowledge on Medicinal Plants Used by the Tribal Communities of Gokand Valley, District Buner, Khyber Pakhtunkhwa, Pakistan. PLANTS (BASEL, SWITZERLAND) 2020; 9:E1001. [PMID: 32781736 PMCID: PMC7463859 DOI: 10.3390/plants9081001] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/08/2020] [Revised: 07/30/2020] [Accepted: 08/02/2020] [Indexed: 02/06/2023]
Abstract
The current study on the traditional use of medicinal plants was carried out from February 2018 to March 2020, in Gokand Valley, District Buner, Pakistan. The goal was to collect, interpret, and evaluate data on the application of medicinal plants. Along with comprehensive notes on individual plants species, we calculated Use Value (UV), Relative Frequency of Citation (RFC), Use Report (UR), Fidelity Level (FL), Informant Consensus Factor (FCI), as well as Family Importance Value (FIV). During the current study, a total of 109 species belonging to 64 families were reported to be used in the treatment of various ailments. It included three families (four species) of Pteridophytes, 58 families (99 species) of angiosperm, one family (three species) of Gymnosperms, and two families (three species) of fungi. The article highlights the significance of domestic consumption of plant resources to treat human ailments. The UV varied from 0.2 (Acorus calamus L.) to 0.89 (Acacia modesta Wall.). The RFC ranged from 0.059 (Acorus calamus L. and Convolvulus arvensis L.) to 0.285 (Acacia modesta Wall.). The species with 100% FL were Acacia modesta Wall. and the fungus Morchella esculenta Fr., while the FCI was documented from 0 to 0.45 for gastro-intestinal disorders. The conservation ranks of the medicinal plant species revealed that 28 plant species were vulnerable, followed by rare (25 spp.), infrequent (17 spp.), dominant (16 spp.), and 10 species endangered. The traditional use of plants needs conservation strategies and further investigation for better utilization of natural resources.
Collapse
Affiliation(s)
- Sulaiman
- Department of Botany, University of Peshawar, Peshawar 25000, KP, Pakistan; (S.); (S.S.); (S.K.)
| | - Sikandar Shah
- Department of Botany, University of Peshawar, Peshawar 25000, KP, Pakistan; (S.); (S.S.); (S.K.)
| | - Sheharyar Khan
- Department of Botany, University of Peshawar, Peshawar 25000, KP, Pakistan; (S.); (S.S.); (S.K.)
| | - Rainer W. Bussmann
- Department of Ethnobotany, Institute of Botany, Ilia State University, Tbilisi 0105, Georgia;
| | - Maroof Ali
- College of Life Science, Anhui Normal University, Wuhu 241000, China;
| | - Dildar Hussain
- School of Computational Science Korea Institute for Advanced Study (KIAS), 85 Hoegiro Dongdaemun-gu, Seoul 02455, Korea
| | - Wahid Hussain
- Department of Botany, Govt. Post Graduate College, Parachinar 26000, KP, Pakistan
| |
Collapse
|
7
|
Vahekeni N, Neto PM, Kayimbo MK, Mäser P, Josenando T, da Costa E, Falquet J, van Eeuwijk P. Use of herbal remedies in the management of sleeping sickness in four northern provinces of Angola. JOURNAL OF ETHNOPHARMACOLOGY 2020; 256:112382. [PMID: 31743767 DOI: 10.1016/j.jep.2019.112382] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/19/2019] [Revised: 11/02/2019] [Accepted: 11/10/2019] [Indexed: 06/10/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE This study reports for the first time on the use of folk medicine to treat sleeping sickness and its symptoms in four endemic provinces in northern Angola. By interviewing both traditional practitioners and confirmed patients, it highlights reasons to recourse to folk medicine, the plant species used for this affection as well as arises awareness about the use of particular plants showing potential risks. AIM OF THE STUDY The aims of this explorative study were three-fold. Firstly, it informed on access to, and use of plant-based medicine as first-choice treatment by infected persons. Secondly, it aimed at collecting comprehensive data from patients and traditional healers on herbal remedies in order to identify plant species used in the management of the disease. Thirdly, it served as contribution for primary indication of potential risk of use associated with the studied plants and their preparation. MATERIALS AND METHODS The study was conducted in 4 endemic provinces of Angola, namely Bengo, Zaire, Kwanza Norte and Uíge. We explored the use of herbal remedies by conducting structured and semi-structured interviews within two distinct study populations. The first group comprises 30 patients who had been diagnosed for trypanosomiasis and treated by the reference treatment. The second group included 9 traditional practitioners who had already treated sleeping sickness. The plants that were cited during the interviews were collected during field walks under supervision of a traditional healer, then authenticated and deposited at the National Herbarium in Luanda. RESULTS Of the 30 included patients, 12 (40%) had turned to folk medicine in the management of trypanosomiasis and related symptoms. 7 medicinal plants were reported by this group. Considering the key motivation to consult a traditional practitioner, two main factors accounted for half of the cases: "past experience with folk medicine" and "family habit". Out of 9 traditional practitioners' interviewees, 26 medicinal plants were cited. Roots and leaves were the most used plant parts, and decoction was the common mode of preparation. Evidence for antitrypanosomal activity in the scientific literature was found for 56% (17 of 30) of the identified plant species. The most cited plant was Crossopteryx febrifuga (UR = 6). Some of the cited plants, as for example Aristolochia gigantea, raised concern about potential toxicity. CONCLUSIONS With 40% of infected persons having turned first to folk medicine before consulting a medical doctor, this explorative study points out that plant-based medicines play an important role in local dynamics of health care. It highlights the need for primary assessment of potential risk of use related to the herbal recipes, and for reporting it to the concerned population. This first ethnobotanical study on trypanosomiasis in endemic provinces of Angola provides information on 30 plants, of which some had been identified as promising for further pharmacological research. Our results provide a first step towards the validation and valorization of Angolan herbal remedies for sleeping sickness.
Collapse
Affiliation(s)
- Nina Vahekeni
- Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 53, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland; Nacional Center of Scientific Investigation (CNIC), Luanda, Angola.
| | - Pedro Menezes Neto
- Centro de Estudos e Investigação Científica de Botânica, Universidade Agostinho Neto, Luanda, Angola.
| | | | - Pascal Mäser
- Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 53, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland.
| | - Théophile Josenando
- Instituto de Combate e Controlo das Tripanossomíasses (ICCT), Luanda, Angola.
| | - Esperança da Costa
- Centro de Estudos e Investigação Científica de Botânica, Universidade Agostinho Neto, Luanda, Angola.
| | | | - Peter van Eeuwijk
- Swiss Tropical and Public Health Institute (Swiss TPH), Socinstr. 53, 4051, Basel, Switzerland; University of Basel, Petersplatz 1, 4001, Basel, Switzerland; Institute of Social Anthropology, University of Basel, Münsterplatz 19, 4051, Basel, Switzerland.
| |
Collapse
|
8
|
Saberi R, Fakhar M, Asfaram S, Akhtari J, Nakhaei M, Keighobadi M. A Systematic Literature Review of Curcumin with Promising Antileishmanial Activity. Infect Disord Drug Targets 2020; 21:363-369. [PMID: 32448108 DOI: 10.2174/1871526520666200525013458] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2020] [Revised: 04/24/2020] [Accepted: 04/28/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND Curcumin (CUR) is a bright yellow chemical and it is used as an additive in foods. Recently CUR and its associated bioactive compounds have received much attention in the literature review. The aim of this systematic review is to overview the antileishmanial properties of CUR and its mechanism; perhaps the results of this study will be used for therapeutic and preventive purposes. METHODS Following the PRISMA guidelines, international databases were systematically searched for studies published until September 2019. Articles related to the subject were selected and included in this systematic review. RESULTS A total of 15 articles met our eligibility criteria. Then, the effect of CUR and its associated bioactive compounds on Leishmania species was evaluated. In most studies, CUR/derivatives were tested on L. major and in vitro condition. Most investigations were conducted on the promastigote rather than the more relevant intracellular amastigote stage. Our results showed that CUR overcomes the inhibitory effect of nitric oxide (NO) on Leishmania parasites. CONCLUSION This review indicated that CUR derivatives, instead of CUR alone showed a high potential to serve as an effective herbal drug against leishmaniasis. Moreover, we concluded that the antileishmanial activity of CUR/bioactive compounds is mostly due to increased oxidative stress and apoptosis.
Collapse
Affiliation(s)
- Reza Saberi
- Department of Parasitology, Toxoplasmosis Research Center, School of Medicine, Mazandaran University of Medical Sciences, P.O Box: 48471-91971, Sari, Iran
| | - Mahdi Fakhar
- Department of Parasitology, Toxoplasmosis Research Center, School of Medicine, Mazandaran University of Medical Sciences, P.O Box: 48471-91971, Sari, Iran
| | - Shabnam Asfaram
- Department of Parasitology, Toxoplasmosis Research Center, School of Medicine, Mazandaran University of Medical Sciences, P.O Box: 48471-91971, Sari, Iran
| | - Javad Akhtari
- Department of Medical Nanotechnology, Toxoplasmosis Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
| | - Maryam Nakhaei
- Department of Parasitology, Toxoplasmosis Research Center, School of Medicine, Mazandaran University of Medical Sciences, P.O Box: 48471-91971, Sari, Iran
| | - Masoud Keighobadi
- Department of Parasitology, Toxoplasmosis Research Center, School of Medicine, Mazandaran University of Medical Sciences, P.O Box: 48471-91971, Sari, Iran
| |
Collapse
|